A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/21 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2632024
Methods of treating an autoimmune condition by administering IFN.tau. are described. IFN.tau. is administered orally at a dose sufficient to achieve obtain a desired clinical endpoint, such as a reduction in new contrast- enhanced brain lesions in multiple sclerosis patients.
La présente invention concerne des procédés de traitement d'une maladie auto-immune consistant en l'administration d'IFN.tau.. L'IFN.tau. est administré oralement à une dose suffisante pour obtenir un critère d'évaluation clinique souhaité, notamment une réduction de nouvelles lésions cérébrales à contraste rehaussé chez des patients atteints de sclérose en plaques
Liu Chih-Ping
Villarete Lorelie H.
Gowling Lafleur Henderson Llp
Pepgen Corporation
LandOfFree
Treatment of multiple sclerosis using interferon-tau does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of multiple sclerosis using interferon-tau, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of multiple sclerosis using interferon-tau will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1882742